Domača stranAUROPHARMA • NSE
add
Aurobindo Pharma Ltd
Prejšnji trg. dan.
1227,45 ₹
Dnevni razpon
1218,10 ₹ - 1236,55 ₹
Letni razpon
958,50 ₹ - 1592,00 ₹
Tržna kapitalizacija
718,16 mrd. INR
Povprečni obseg
895,22 tis.
Razm. P/E
19,97
Dividendna donosnost
-
Primarna borza
NSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (INR) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 77,96 mrd. | 7,99 % |
Stroški poslovanja | 34,02 mrd. | 13,51 % |
Čisti dohodek | 8,17 mrd. | 7,95 % |
Čista dobičkovnost prihodkov | 10,48 | −0,10 % |
Earnings per share | 14,00 | 9,12 % |
EBITDA | 15,77 mrd. | 16,15 % |
Efektivna davčna stopnja | 32,34 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (INR) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 68,68 mrd. | −3,93 % |
Skupna sredstva | 480,94 mrd. | 9,50 % |
Skupne obveznosti | 172,09 mrd. | 9,41 % |
Celoten lastniški kapital | 308,85 mrd. | — |
Shares outstanding | 583,84 mio. | — |
Razmerje P/B | 2,32 | — |
Donosnost sredstev | — | — |
Donosnost kapitala | 7,81 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (INR) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 8,17 mrd. | 7,95 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Datum ustanovitve
1986
Sedež organizacije
Spletno mesto
Zaposleni
26.015
